Skip to main content
. 2016 Dec 15;2016(12):CD006918. doi: 10.1002/14651858.CD006918.pub3

2.21. Analysis.

2.21

Comparison 2 RISPERIDONE + CLOZAPINE vs PLACEBO + CLOZAPINE, Outcome 21 Adverse effects: 7b. metabolic ‐ average endpoint value on lipid profile ‐ short term (up to 12 weeks).